Veeco (VECO) Q1 2026 Earnings Call Transcript

Veeco reported Q1 revenue of $158 million with non-GAAP EPS of $0.14, both in line with guidance, while reaffirming full-year 2026 revenue of $740 million to $800 million and EPS of $1.50 to $1.85. The company disclosed over $250 million in new orders tied to indium phosphide laser manufacturing, supporting a 10x expansion in Spectre IBD capacity and shipments starting in Q3 with a larger ramp in Q1 2027. Results were tempered by an $8 million revenue and margin hit from an LSA shipment blocked for a China customer under export licensing requirements.

Analysis

VECO is increasingly a capacity-constrained option on two separate demand waves: AI infra in backend/packaging and optical interconnect in silicon photonics. The important second-order effect is that the company is not just winning incremental share; it is converting design wins into a multi-quarter delivery backlog that should mechanically widen operating leverage as the mix shifts away from China/mature-node exposure and toward higher-content, higher-margin specialty tools. That makes the next 2-3 quarters less about headline revenue and more about whether supply-chain execution can keep pace with the demand signal.

The clearest beneficiary may actually be ACLS by association, not because of direct overlap in product economics, but because the merger now serves as a de-risking framework for customers who want a broader process portfolio and more continuity of supply. The flip side is that China export controls are no longer a nuisance item; they are a recurring gating factor that can suppress near-term conversion and create quarter-to-quarter margin noise even when end-demand is strong elsewhere. If that restriction broadens, the market will likely re-rate the story from "growth with controls" to "growth with episodic air pockets," which would compress the multiple.

The underappreciated catalyst is the 2027 timing: management is explicitly signaling that the real step-up in both Spectre and advanced packaging capacity lands next year, meaning 2026 consensus may still understate the true earnings power if the orders convert on schedule. But that also means the stock can become a crowded "show-me" trade into year-end: any slip in qualification, capex ramp, or customer timing could knock 10-15% off the name quickly because the market is already discounting a clean inflection. The contrarian miss is that the current setup may be less about a one-year earnings beat and more about whether VECO can defend its claimed structural role in the optical supply chain versus cheaper alternative process paths.

From a portfolio perspective, the best asymmetry is to own VECO against a China/export-control hedge rather than outright chase strength. The company has enough backlog and end-market momentum to support upside, but the path will likely be noisy and the stock should trade with elevated event risk until the 2027 capacity narrative is validated.

Key Decisions for Investors

• Long VECO on a 3-6 month horizon into the Q3/Q4 shipment ramp; target upside from backlog conversion and margin expansion, but size for 10-15% pullback risk on timing slips.
• Pair trade: long VECO / short a China-exposed semiconductor equipment basket (or a relevant China WFE proxy) to isolate export-control headwinds versus AI/optical demand strength.
• Add ACLS only on merger-spread dislocation, not momentum; the better entry is on any regulatory-delay selloff, with the thesis that combination value improves if VECO’s capacity ramp needs scale and broader customer coverage.
• Use VECO call spreads expiring after Q1 2027 to express the capacity-ramp thesis; that window aligns with management’s stated inflection and offers better convexity than common stock after the recent order-driven run.
• If VECO rallies hard on backlog headlines, trim 20-30% and look to re-enter on any export-control or execution-related drawdown; this is a staircase story, not a straight line.